La evaluación de resultados (outcomes) y de su relevancia clínica en cardiología: Especial referencia a la calidad de vida

Revista Espanola de Cardiologia

Volumn 50, Issue 3, 1997, Pages 192-200

  Cuixart, Carlos Brotons ^a   Miralda, Cayetano Permanyer ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344753072     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Agency for Health Care Policy and Research. Medical treatment effectiveness research (AHCPR program note). Rockville, MD: US, Government Printing Office, 1990.
2. Goldberg HI, Cummings MA, Steinberg EP, Ricci EM, Shannon T, Soumera SB et al. Deliberations on the dissemination of PORT products: translating research findings into improved patient outcomes. Med Care 1994; 32 (Supl): JS90-JS110.
3. Jollis JC, Ancukiewicz M, DeLong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med 1993; 119: 844-850.
4. Hannan EL, Kilburn HJr, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery: does it matter? Med Care 1992; 30: 892-907.
5. Hannan EL, Kilburn HJr, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State: an analysis of risk factors and hospital mortality rates. JAMA 1990; 264: 2.768-2.774.
6. Hannan EL, Kilburn HJr, Racz M, Shields E, Chassin MR. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA 1994; 271: 761-766.
7. Leape LL, Hilborne LH, Park RE, Berstein SJ The appropriatness of use of coronary artery bypass graft surgery in New York State. JAMA 1993; 269: 761-765.
8. Hilborne LH, Leape LL, Bernstein SJ, Park RE. The appropriatness of use of percutaneous transluminal coronary angioplasty in New York State. JAMA 1993; 269: 766-769.
9. Ware JE. Conceptualizing disease impact and treatment outcomes. Cancer 1984; 53 (Supl): 2.316-2.323.
10. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-629.
11. Guyatt GH, Cook DJ. Health status, quality of life, and the individual. JAMA 1994; 272: 630-631.
12. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. En: Spilker B, editor. Quality of life assessments in clinical trials. Nueva York: Raven Press, 1990; 16.
13. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273: 5.965.
14. Guyatt GH, Jaeschke R. Measurements in clinical trials: choosing the appropriate approach. En: Spilker B, editor. Quality of life assessments in clinical trials. Nueva York: Raven Press, 1990; 37-46.
15. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. Nueva York: Oxford University Press, 1987; 285-290.
16. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 185-188.
17. Alonso J, Prieto L, Antó JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res 1994; 3: 385-393.
18. Ware JE Jr. Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36). Med Care 1992; 30: 473-482.
19. Alonso J. Prieto L, Antó JM. La versión espan̄ola del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 1995; 104: 771-776.
20. Jenkinson C, Layte R, Wright L, Coulter A. The UK SF-36: an analysis and interpretation manual. Oxford: Health Services Research Unit, Department of Public Health and Primary Care, University of Oxford, 1996.
21. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation 1982; 66 (Supl 3): 56-66.
22. Rector TS, Johnson G, Dunkman B, Daniels G, Farrell L, Henrick A et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. Circulation 1993; 87 (Supl 4): 71-77.
23. Nissinen A, Wiklund I, Lahti T, Akkila J, Wilson A, Wahl M et al. Antianginal therapy and quality of life. A comparison of the effects of transdermal nitroglycerin and long-acting oral nitrates. J Clin Epidemiol 1991; 44: 989-997.
24. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice. Are available health surveys adequate? Qual Life Res 1995; 4: 293-307.
25. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1.657-1.664.
26. Cox J, Naylor CD. The Canadian Cardiovascular Society grading scale for angina pectoris: is it time for refinements? Ann Intern Med 1992; 117: 677-683.
27. Kubo SH, Gollub S, Bourge R et al. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. Circulation 1992; 85: 942-949.
28. Rogers WJ, Johnstone DE, Yusuf S, Rahko P, Cobb F, Jessup M et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol 1994; 23: 393-400.
29. O'Brien BJ, Buxton MJ, Ferguson BA, Weiner DH, Gallagher P, Bittner VA. Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. J Chron Dis 1987; 40 (Supl 1): 137-153.
30. Guyatt GH. Measurement of health-related quality of life in heart failure. J Am Coll Cardiol 1993; 22 (Supl A): 185A-191A.
31. Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 1988; 2: 4-8.
32. Permanyer Miralda G, Alonso J, Anto JM, Alijarde Guimerá M, Soler-Soler J. Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol 1991; 44: 779-786.
33. Marquis P, Fayol C, Joire JE. Clinical validation of a quality of life questionnaire in angina pectoris patients. Eur Heart J 1995; 16: 1.554-1.560.
34. Permanyer Miralda G, Brotons C, Cascant P, Moral I, Alonso J, Soler Soler J. Valoración de la calidad de vida relacionada con la salud a los dos años de la cirugía coronaria. Med Clin (Barc) 1996. En prensa.
35. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326: 10-16.
36. Strauss WE, Fortin T, Hartigan P, Folland ED, Parisi AF, and the Veterans Affair ACME investigators. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Circulation 1995; 92: 1.710-1.719.
37. Caine N, Harrison SC, Sharples LD, Wallwork J. Prospective study of quality of life before and after coronary artery bypass grafting. Br Med J 1991; 302: 511-516.
38. Guadagnoli E, Ayanian JZ, Cleary PD. Comparison of patient-reported outcomes after elective coronary artery bypass grafting in patients aged > and < 65 years. Am J Cardiol 1992; 70: 60-64.
39. Glower DD, Christopher TD, Milano CA, White WD, Smith LR, Jones RH et al. Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. Am J Cardiol 1992; 70: 567-571.
40. Pinna Pintor PP, Torta R, Bartolozzi S, Borio R, Caruzzo E, Ciccolin A et al. Clinical outcome and emotional-behavioural status after isolated coronary surgery. Qual Life Res 1992; 1: 177-185.
41. Chocron S, Etievent JP, Viel JF, Dussaucy A, Clement F, Alwan K et al. Prospective study of quality of life before and after open heart operations. Ann Thorac Surg 1996; 61: 153-157.
42. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 651-654.
43. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994; 331: 1.130-1.135.
44. Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care 1995; 33: 598-610.